CJRB-402

N/A

Report date: 2024/01/10 16:06:19

Base Information

Drug NameCJRB-402
Drug Alias Namelive biotherapeutic preparation (MicroRx, severe neutrophilic asthma), 4d pharmaMRx-4DP-0004MRx-4DP0004MRx-0004
ClassificationBiologics > Live BiotherapeuticNatural product/Extract > Microbial extract
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Asthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator Companies4d Pharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies4d Pharma Plc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Asthma

Other Information

ATC CodeN/A
Related LinksN/A